Catalyst

Slingshot members are tracking this event:

Pivotal trials of AVXS-101 for SMA Type 1 expected to initiate in the first half of 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
AVXS

100%

Additional Information

Additional Relevant Details AveXis Announces Single-Arm Design for U.S. Pivotal Study of AVXS-101 in SMA Type 1 Patients
http://investors.ave...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 06, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Pivotal Trial, Avxs-101, Sma Type 1